Your Cancer Diagnosis May Be Linked to Your Heartburn Medication
Zantac is one of the most popular medications taken for heartburn – at one point, it was the top-selling drug in history! That’s why it is so shocking, and has such far reaching consequences, that Zantac may increase your risk of cancer.
If you or someone you love has been diagnosed with cancer and is taking or has taken Zantac for at least a year, you may be eligible for significant compensation.
Zantac Recall Timeline
- The potential carcinogen NDMA is found in ranitidine.
- Zantac manufacturer Sanofi voluntarily recalls Zantac products from stores.
- Major drugstores including CVS and Walgreens pull Zantac and its generic, ranitidine, from their shelves, regardless of the manufacturer.
November 2019 – February 2020
- Numerous manufacturers of generic ranitidine voluntarily recall their products from shelves.
- The Food and Drug Administration (FDA) requests all manufacturers of any product containing ranitidine to remove their products from shelves effective immediately.
- The FDA advises all consumers to stop taking over-the-counter ranitidine effective immediately, and to dispose of any Zantac or ranitidine medication in their homes.
What Type of Cancer Does Zantac Cause?
NDMA, the likely carcinogen found in Zantac, has been linked to numerous types of cancer, including:
We Help Zantac Cancer Victims
Drug manufacturers have a responsibility to reduce risks facing the consumers of their products, and if risks can’t be avoided, to properly communicate risks to consumers. Drug manufacturers should also make sure any side effects are not worse than the condition the medication is intended to cure before allowing it to go on the market.
The producers of Zantac and ranitidine failed on all counts, and can and should be held responsible for your cancer-related expenses as a result. We want to help you get the compensation you need after your cancer diagnosis.
Contact our defective drug attorneys today for a free, no–obligation consultation.